Mallinckrodt Exec Says Acthar Price Hikes Were Necessary
A Mallinckrodt executive defended the pricing and marketing of the drugmaker's Acthar gel on Monday as a pair of insurers presented a Delaware judge with the last of their evidence that...To view the full article, register now.
Already a subscriber? Click here to view full article